We are live on
!
Find out more
Altimmune
ALT
ALT
173 hedge funds and large institutions have $214M invested in Altimmune in 2026 Q1 according to their latest regulatory filings, with 30 funds opening new positions, 82 increasing their positions, 34 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
225% more call options, than puts
Call options by funds: $10.4M | Put options by funds: $3.21M
141% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 34
8% more capital invested
Capital invested by funds: $198M → $214M (+$15.5M)
0.76% more ownership
Funds ownership: 52.56% → 53.32% (+0.76%)
9% less first-time investments, than exits
New positions opened: 30 | Existing positions closed: 33
4% less funds holding
Funds holding: 181 → 173 (-8)
Holders
173
Holders Change
-8
Holders Change %
-4.42%
% of All Funds
2.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
30
Increased
82
Reduced
34
Closed
33
Calls
$10.4M
Puts
$3.21M
Net Calls
+$7.22M
Net Calls Change
+$9.84M
Top Buyers
| 1 |
Marshall Wace
London,
United Kingdom
|
+$13.1M |
| 2 |
BlackRock
New York
|
+$13.1M |
| 3 |
Millennium Management
New York
|
+$13M |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
+$11.2M |
| 5 |
State Street
Boston,
Massachusetts
|
+$8.6M |
Top Sellers
| 1 |
Jane Street
New York
|
-$7.57M |
| 2 |
TCM
Tang Capital Management
San Diego,
California
|
-$6.22M |
| 3 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$4.08M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$3.77M |
| 5 |
D.E. Shaw & Co
New York
|
-$2.62M |
